MIT Researchers Use AI to Develop Heat-Stable mRNA Vaccines Eliminating Ultra-Cold Storage Need

Researchers at MIT have engineered mRNA vaccines capable of remaining stable at room temperature for up to one year using artificial intelligence, potentially eliminating the need for ultra-cold storage infrastructure that has long constrained vaccine distribution. The breakthrough, published in *Nature Biotechnology* on September 28, 2026, addresses one of the most significant logistical barriers to global vaccine deployment.